|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02415 MEDSCI
Nominal 
1.260 0.000 (0.000%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 270,374 | 3.741% | 260,623 | 349,194 | 348,950 | 297,731 |
| Cost of Sales | (109,929) | 11.661% | (98,449) | (132,587) | (142,629) | (107,921) |
| Gross Profit | 160,445 | -1.066% | 162,174 | 216,607 | 206,321 | 189,810 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (13,198) | -6.925% | (14,180) | (831) | (111,884) | (197,134) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 19,524 | -23.426% | 25,497 | 60,450 | (96,292) | (147,058) | |
| Taxation | (1,587) | 199.434% | (530) | (5,408) | (3,589) | (3,972) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 17,937 | -28.157% | 24,967 | 55,042 | (99,881) | (151,030) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (8,385) | -47.741% | (16,045) | (15,095) | (10,022) | (4,574) |
| Depreciation & Amortisation | 5,626 | -21.807% | 7,195 | 8,350 | 8,378 | 8,476 |
| Directors' Emoluments | -- | -- | 21,309 | 5,351 | 3,650 | 2,610 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 3.000 | -40.000% | 5.000 | 11.000 | -21.000 | -- |
| DPS (cts) | 0.964 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | 32.139% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.101 | 0.073 | (0.030) | -- |
| NBV per share ($) | 1.945 | -- | 1.926 | 1.845 | -- | -- |
| Remarks: | Real time quote last updated: 10/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 17,937 |
| %Change | -28.157% |
| EPS / (LPS) | RMB 0.030 |
| NBV Per Share (¥) | RMB 1.945 |